Male reproductive system parameters in a two-generation reproduction study of ammonium perfluorooctanoate in rats and human relevance

Toxicology

Volumn 271, Issue 1-2, 2010, Pages 64-72

  York, Raymond G ^a   Kennedy Jr , Gerald L ^b   Olsen, Geary W ^c   Butenhoff, John L ^c  

^a WIL RESEARCH LABORATORIES   (United States)

^b DUPONT COMPANY   (United States)

^c 3M COMPANY   (United States)

Author keywords

Ammonium perfluorooctanoate; Male rats; PFOA; Reproduction; Sperm

Indexed keywords

AMMONIUM PERFLUOROOCTANOIC ACID; PERFLUOROOCTANOIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; MALE; MALE FERTILITY; NONHUMAN; ORGAN WEIGHT; PRIORITY JOURNAL; RAT; REPRODUCTIVE TOXICITY; SPERMATID; SPERMATOZOON COUNT; SPERMATOZOON DENSITY; SPERMATOZOON MOTILITY;

ANIMALS; ENVIRONMENTAL POLLUTANTS; FEMALE; FLUOROCARBONS; HUMANS; MALE; OCTANOIC ACIDS; ORGAN SIZE; PREGNANCY; RATS; REPRODUCTION; SPERM COUNT; SPERM MOTILITY; SPERMATOZOA; TESTIS;

ANIMALIA; RATTUS;

EID: 77951298264     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2010.03.005     Document Type: Article

References (42)

1. Biegel L.B., Hurtt M.E., Frame S.R., O'Connor J.C., Cook J.C. Mechanisms of extrahepatic tumor induction by peroxisome proliferators in male CD rats. Toxicol. Sci. 2001, 60:44-55.
2. Biegel L.B., Liu R.C., Hurtt M.E., Cook J.C. Effects of ammonium perfluorooctanoate on Leydig cell function: in vitro, in vivo, and ex vivo studies. Toxicol. Appl. Pharmacol. 1995, 134:18-25.
3. Butenhoff J., Costa G., Elcombe C., Farrar D., Hansen K., Iwai H., Jung R., Kennedy G., Lieder P., Olsen G., Thomford P. Toxicity of ammonium perfluorooctanoate in male cynomolgus monkeys after oral dosing for 6 months. Toxicol. Sci. 2002, 69:244-257.
4. Butenhoff J.L., Gaylor D.W., Moore J.A., Olsen G.W., Rodricks J., Mandel J.H., Zobel L.R. Characterization of risk for general population exposure to perfluorooctanoate. Regul. Toxicol. Pharmacol. 2004, 39:363-380.
5. Butenhoff J.L., Kennedy G.L., Frame S.R., O'Connor J.C., York R.G. The reproductive toxicology of ammonium perfluorooctanoate (APFO) in the rat. Toxicology 2004, 196:95-116.
6. Butenhoff J.L., Kennedy G.L., Hinderliter P.M., Lieder P.H., Jung R., Hansen K.J., Gorman G.S., Noker P.E., Thomford P.J. Pharmacokinetics of perfluorooctanoate in cynomolgus monkeys. Toxicol. Sci. 2004, 82:394-406.
7. Calafat A.M., Wong L.Y., Kuklenyik Z., Reidy J.A., Needham L.L. Polyfluoroalkyl chemicals in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000. Environ. Health Perspect. 2007, 115:1596-1602.
8. Cook J.C., Murray S.M., Frame S.R., Hurtt M.E. Induction of Leydig cell adenomas by ammonium perfluorooctanoate: a possible endocrine-related mechanism. Toxicol. Appl. Pharmacol. 1992, 113:209-217.
9. Costa G., Sartori S., Consonni D. Thirty years of medical surveillance in perfluorooctanoic acid production workers. J. Occup. Environ. Med. 2009, 51:364-372.
10. DuPont, 2007. Cross-sectional study of lipids and liver enzymes related to a serum biomarker of exposure (ammonium perfluorooctanoate or APFO) as part of a general health survey in a cohort of occupationally exposed workers. Appendix 1. Additional analysis for hematology, chemistry and hormones, Unpublished data.
11. Dunn O.J. Multiple comparisons using rank sums. Technometrics 1964, 6:241-252.
12. Dunnett C.W. A multiple comparison procedure for comparing several treatments with a control. J. Amer. Stat. Assoc. 1955, 50:1096-1121.
13. Emmett E.A., Shofer F.S., Zhang H., Freeman D., Desai C., Shaw L.M. Community exposure to perfluorooctanoate: relationships between serum concentrations and exposure sources. J. Occup. Environ. Med. 2006, 48:759-770.
14. Eriksen K.T., Sorensen M., McLaughlin J.K., Lipworth L., Tjonneland A., Overvad K., Raaschou-Nielsen O. Perfluorooctanoate and perfluorooctanesulfonate plasma levels and risk of cancer in the general Danish population. J. Natl. Cancer Inst. 2009, 101:605-609.
15. Fei C., McLaughlin J.K., Lipworth L., Olsen J. Maternal levels of perfluorinated chemicals and subfecundity. Hum. Reprod. 2009, 24:1200-1205.
16. Feron V.J., de Groot A.P., Spanjers M.T., Til H.P. An evaluation of the criterion " organ weight" under conditions of growth retardation. Food Cosmet. Toxicol. 1973, 11:85-94.
17. Gilliland F.D. Fluorocarbons and Human Health: Studies in an Occupational Cohort 1992, School of Public Health, University of Minnesota, Minneapolis, Minnesota.
18. Gilliland F.D., Mandel J.S. Serum perfluorooctanoic acid and hepatic enzymes, lipoproteins, and cholesterol: a study of occupationally exposed men. Am. J. Ind. Med. 1996, 29:560-568.
19. Hansen K.J., Clemen L.A., Ellefson M.E., Johnson H.O. Compound-specific, quantitative characterization of organic fluorochemicals in biological matrices. Environ. Sci. Technol. 2001, 35:766-770.
20. Houde M., Martin J.W., Letcher R.J., Solomon K.R., Muir D.C. Biological monitoring of polyfluoroalkyl substances: a review. Environ. Sci. Technol. 2006, 40:3463-3473.
21. Joensen U.N., Bossi R., Leffers H., Jensen A.A., Skakkebaek N.E., Jorgensen N. Do perfluoroalkyl compounds impair human semen quality?. Environ. Health Perspect. 2009, 117:923-927.
22. Jorgensen N., Carlsen E., Nermoen I., Punab M., Suominen J., Andersen A.G., Andersson A.M., Haugen T.B., Horte A., Jensen T.K., Magnus O., Petersen J.H., Vierula M., Toppari J., Skakkebaek N.E. East-West gradient in semen quality in the Nordic-Baltic area: a study of men from the general population in Denmark, Norway, Estonia and Finland. Hum. Reprod. 2002, 17:2199-2208.
23. Kennedy G.L., Butenhoff J.L., Olsen G.W., O'Connor J.C., Seacat A.M., Perkins R.G., Biegel L.B., Murphy S.R., Farrar D.G. The toxicology of perfluorooctanoate. Crit. Rev. Toxicol. 2004, 34:351-384.
24. Lau C., Anitole K., Hodes C., Lai D., Pfahles-Hutchens A., Seed J. Perfluoroalkyl acids: a review of monitoring and toxicological findings. Toxicol. Sci. 2007, 99:366-394.
25. Lau C., Butenhoff J.L., Rogers J.M. The developmental toxicity of perfluoroalkyl acids and their derivatives. Toxicol. Appl. Pharmacol. 2004, 198:231-241.
26. Liu R.C., Hurtt M.E., Cook J.C., Biegel L.B. Effect of the peroxisome proliferator, ammonium perfluorooctanoate (C8), on hepatic aromatase activity in adult male Crl:CD BR (CD) rats. Fundam. Appl. Toxicol. 1996, 30:220-228.
27. Luebker D.J., Case M.T., York R.G., Moore J.A., Hansen K.J., Butenhoff J.L. Two-generation reproduction and cross-foster studies of perfluorooctanesulfonate (PFOS) in rats. Toxicology 2005, 215:126-148.
28. Luebker D.J., York R.G., Hansen K.J., Moore J.A., Butenhoff J.L. Neonatal mortality from in utero exposure to perfluorooctanesulfonate (PFOS) in Sprague-Dawley rats: dose-response, and biochemical and pharmacokinetic parameters. Toxicology 2005, 215:149-169.
29. Midasch O., Drexler H., Hart N., Beckmann M.W., Angerer J. Transplacental exposure of neonates to perfluorooctanesulfonate and perfluorooctanoate: a pilot study. Int. Arch. Occup. Environ. Health 2007, 80:643-648.
30. Oishi S., Oishi H., Hiraga K. The effect of food restriction for 4 weeks on common toxicity parameters in male rats. Toxicol. Appl. Pharmacol. 1979, 47:15-22.
31. Olsen G.W., Burris J.M., Burlew M.M., Mandel J.H. Plasma cholecystokinin and hepatic enzymes, cholesterol and lipoproteins in ammonium perfluorooctanoate production workers. Drug Chem. Toxicol. 2000, 23:603-620.
32. Olsen G.W., Butenhoff J.L., Zobel L.R. Perfluoroalkyl chemicals and human fetal development: an epidemiologic review with clinical and toxicological perspectives. Reprod. Toxicol. 2009, 27:212-230.
33. Olsen G.W., Church T.R., Miller J.P., Burris J.M., Hansen K.J., Lundberg J.K., Armitage J.B., Herron R.M., Medhdizadehkashi Z., Nobiletti J.B., O'Neill E.M., Mandel J.H., Zobel L.R. Perfluorooctanesulfonate and other fluorochemicals in the serum of American Red Cross adult blood donors. Environ. Health Perspect. 2003, 111:1892-1901.
34. Olsen G.W., Gilliland F.D., Burlew M.M., Burris J.M., Mandel J.S., Mandel J.H. An epidemiologic investigation of reproductive hormones in men with occupational exposure to perfluorooctanoic acid. J. Occup. Environ. Med. 1998, 40:614-622.
35. Olsen G.W., Mair D.C., Church T.R., Ellefson M.E., Reagen W.K., Boyd T.M., Herron R.M., Medhdizadehkashi Z., Nobiletti J.B., Rios J.A., Butenhoff J.L., Zobel L.R. Decline in perfluorooctanesulfonate and other polyfluoroalkyl chemicals in American Red Cross adult blood donors, 2000-2006. Environ. Sci. Technol. 2008, 42:4989-4995.
36. Olsen G.W., Zobel L.R. Assessment of lipid, hepatic, and thyroid parameters with serum perfluorooctanoate (PFOA) concentrations in fluorochemical production workers. Int. Arch. Occup. Environ. Health 2007, 81:231-246.
37. Sakr C.J., Kreckmann K.H., Green J.W., Gillies P.J., Reynolds J.L., Leonard R.C. Cross-sectional study of lipids and liver enzymes related to a serum biomarker of exposure (ammonium perfluorooctanoate or APFO) as part of a General Health Survey in a cohort of occupationally exposed workers. J. Occup. Environ. Med. 2007, 49:1086-1096.
38. Sakr C.J., Leonard R.C., Kreckmann K.H., Slade M.D., Cullen M.R. Longitudinal study of serum lipids and liver enzymes in workers with occupational exposure to ammonium perfluorooctanoate. J. Occup. Environ. Med. 2007, 49:872-879.
39. Snedecor G.W., Cochran W.G. Variance test for homogeneity of the binomial distribution. Statistical Methods 1967, Iowa State University Press, Ames, pp. 240-241. 6th Edition.
40. Snedecor G.W., Cochran W.G. Analysis of variance. Statistical Methods 1967, Iowa State University Press, Ames, pp. 258-275. 6th Edition.
41. Sokal R.R., Rohlf F.J. Bartlett's test of homogeneity of variances. Biometry 1969, W.H. Freeman and Co, San Francisco, pp. 370-371.
42. Ubel F.A., Sorenson S.D., Roach D.E. Health status of plant workers exposed to fluorochemicals - a preliminary report. Am. Ind. Hyg. Assoc. J. 1980, 41:584-589.